Life Scientist > Life Sciences

Gut microbiome–autism link flipped on its head

12 November, 2021

Diversity in microbe species found in the guts of children with autism may be due to their restricted dietary preferences, rather than the cause of their symptoms.


Oral hookworm vaccine proves effective in mice

11 November, 2021

The new vaccine targets the hookworm's digestion enzyme (APR 1). When the function of these enzymes is blocked, the parasite starves.


How bipolar disorder changes the brain over time

05 November, 2021

A multicentre longitudinal study has confirmed aberrant changes over time in the brains of people with bipolar disorder.


Alzheimer's spreads differently to how we thought

03 November, 2021

Researchers have used human data to quantify the speed of different processes that lead to Alzheimer's disease.


Ineffective psoriasis drugs block the wrong mechanism

29 October, 2021

Just in time for World Psoriasis Day, UZH researchers have published a study explaining why common psoriasis drugs show insufficient treatment efficacy.


Amino acid supplement could keep dementia at bay

28 October, 2021

In older individuals, low-protein diets are linked to poor maintenance of brain function. Amino acids are the building blocks of proteins.


Trial success as bacteria eradicates pest mosquito

26 October, 2021

The results of a landmark trial have shown how bacteria can successfully sterilise and eradicate the invasive, disease-carrying Aedes aegypti mosquito.


Brain artery variation can indicate risk of aneurysms

26 October, 2021

A new study has measured for the first time a link between variations in size of the brain's arteries and the likelihood of a cerebral aneurysm.


Oxytocin shows no benefit as autism treatment

19 October, 2021

Oxytocin, a naturally occurring hormone that acts as a chemical messenger in the brain, has shown no evidence of helping children with autism gain social skills.


Biomarker for anorexia discovered

18 October, 2021

Australian and Canadian researchers have discovered what they believe is the first biomarker for anorexia nervosa.


COVID-19 booster shots for the severely immunocompromised

11 October, 2021

Australians who are severely immunocompromised will be offered the option to receive a third COVID-19 vaccine dose to boost their protection.


Malaria vaccine for children officially recommended by WHO

08 October, 2021

The World Health Organization is recommending widespread use of the breakthrough RTS,S/AS01 malaria vaccine among children in sub-Saharan Africa.


Opioids could treat inflammatory bowel disease

07 October, 2021

KNT-127 — a drug that targets delta opioid receptors — can reduce pro-inflammatory signals in the colon, indicating the therapeutic potential of opioids in IBD.


Immune cells in the brain can cooperate when needed

01 October, 2021

To break down toxic proteins more quickly, immune cells in the brain can join together to form networks when needed.


Upgrading electrophysiology to take on ALS

30 September, 2021 by Dr Jim Ross*

Work carried out in the lab of Evangelos Kiskinis seeks to create better models of neurological diseases, like ALS, with induced pluripotent stem cells (iPSCs).


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd